{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T06:42:45Z","timestamp":1745131365186},"reference-count":41,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2000,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Serum bactericidal assays (SBAs) for Group B meningococci are considered the methods of choice for the evaluation of functional antimeningococcal antibodies. Many investigators regard SBAs as time- and labor-intensive. Variations in SBA protocols among different laboratories make interpretation of results difficult. Here we describe a fluorescence-based serum bactericidal assay (fSBA) and compare the results obtained with the fSBA to the results obtained with a more conventional SBA. The results generated by both assays were dependent upon the surviving bacteria after incubation, and the assay mixtures contained identical components. Differences between assays lie in how the surviving bacteria are quantified. The fSBA described in the paper uses the fluorescent dye alamarBlue (M. V. Lancaster and R. D. Fields, U.S. patent 5501959, March 1996). The fluorescent signals generated in the fSBA correlate to the oxidative respiration of surviving bacteria. Viable bacteria were detected between 6 and 8 h directly from reaction mixtures in 96-well plates by the fSBA, whereas colonies isolated on semisolid media could be counted after 24 h of incubation. The bactericidal titers generated by both assays were nearly identical. The fSBA described here can be used as an assay for the screening of large quantities of individual sera as complement sources or as a method for the detection of functional antibodies directed against group B<jats:italic>Neisseria meningitidis<\/jats:italic>in both human and mouse antisera.<\/jats:p>","DOI":"10.1128\/jcm.38.8.2878-2884.2000","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T17:57:45Z","timestamp":1577815065000},"page":"2878-2884","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":32,"title":["Detection of Complement-Mediated Antibody-Dependent Bactericidal Activity in a Fluorescence-Based Serum Bactericidal Assay for Group B<i>Neisseria meningitidis<\/i>"],"prefix":"10.1128","volume":"38","author":[{"given":"Kenneth T.","family":"Mountzouros","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Wyeth-Lederle Vaccines and Pediatrics, West Henrietta, New York 14586-9728"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan P.","family":"Howell","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Wyeth-Lederle Vaccines and Pediatrics, West Henrietta, New York 14586-9728"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(94)90396-4"},{"key":"e_1_3_1_3_2","first-page":"125","article-title":"Results of an efficacy trial with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway","volume":"14","author":"Bjune G.","year":"1991","unstructured":"Bjune G. Gronnesby J. K. Hoiby E. A. Closs O. Nokleby H. Results of an efficacy trial with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway.NIPH Ann. (Oslo)141991125132","journal-title":"NIPH Ann. (Oslo)"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)00037-N"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(93)90045-Y"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1992.tb01439.x"},{"key":"e_1_3_1_7_2","first-page":"48","article-title":"Dual attribute continuous monitoring of cell proliferation\/cytotoxicity","volume":"11","author":"Fields R. D.","year":"1993","unstructured":"Fields R. D. Lancaster M. V. Dual attribute continuous monitoring of cell proliferation\/cytotoxicity.Am. Biotechnol. Lab.1119934850","journal-title":"Am. Biotechnol. Lab."},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.4.3.359"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.43.6.757-761.1942"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.5.1.98-102.1972"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.147.3.629"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1307"},{"key":"e_1_3_1_13_2","first-page":"26","article-title":"Immune bacteriolysis reaction in the assessment of immunological effectiveness of serogroup B meningococcal vaccine","volume":"1","author":"Golovina L. I.","year":"1995","unstructured":"Golovina L. I. Kuvakina V. I. Alliluev A. P. Basnak'ian I. A. Sivko R. I. Immune bacteriolysis reaction in the assessment of immunological effectiveness of serogroup B meningococcal vaccine.Klin. Lab. Diagn.119952629 (In Russian.)","journal-title":"Klin. Lab. Diagn."},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00055-6"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.55.12.2878-2883.1987"},{"key":"e_1_3_1_16_2","first-page":"147","article-title":"Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey","volume":"14","author":"Hoiby E. A.","year":"1991","unstructured":"Hoiby E. A. Rosenqvist E. Froholm L. O. Bjune G. Feiring B. Nokleby H. Ronnild E. Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey.NIPH Ann. (Oslo)141991147156","journal-title":"NIPH Ann. (Oslo)"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.85.6.1274-1279.1963"},{"key":"e_1_3_1_18_2","unstructured":"Lancaster M. V. and R. D. Fields. March 1996. U.S. patent 5501959."},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.5.1279"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.4.2.156-167.1997"},{"key":"e_1_3_1_21_2","first-page":"53","article-title":"Recurrent meningococcal infections associated with a functional deficiency of the C8 component of human complement","volume":"39","author":"Matthews N.","year":"1980","unstructured":"Matthews N. Stark J. M. Harper P. S. Doran J. Jones D. M. Recurrent meningococcal infections associated with a functional deficiency of the C8 component of human complement.Clin. Exp. Immunol.3919805359","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0076-6879(94)36013-8"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.10.4419-4424.1994"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.12.5316-5318.1992"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00259-X"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(96)00108-1"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.31.11.3056-3057.1993"},{"key":"e_1_3_1_28_2","first-page":"473","article-title":"A new fluorometric assay for cytotoxicity measurement in vitro","volume":"3","author":"Page B.","year":"1993","unstructured":"Page B. Page M. Noel C. A new fluorometric assay for cytotoxicity measurement in vitro.Int. J. Oncol.31993473476","journal-title":"Int. J. Oncol."},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1086\/514232"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.5.2441-2451.1999"},{"key":"e_1_3_1_31_2","unstructured":"Poolman J. T. Wientjes F. B. Hopman C. T. Zanan H. C. Influence of the length of lipopolysaccharide molecules on the surface exposure of class 1 and class 2 outer membrane proteins of Neisseria meningitidis 2996 (B:2b:P1.2) The pathogenic neisseriae. Schoolnik G. K. 1985 562 570 American Society for Microbiology Washington D.C."},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.26.8.1543-1548.1988"},{"key":"e_1_3_1_33_2","first-page":"169","article-title":"Human antibody responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine: results from ELISA studies","volume":"14","author":"Rosenqvist E.","year":"1991","unstructured":"Rosenqvist E. Hoiby E. A. Bjune G. Bryn K. Closs O. Feiring B. Klem A. Nokleby H. Frolm L. O. Human antibody responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine: results from ELISA studies.NIPH Ann. (Oslo)141991169181","journal-title":"NIPH Ann. (Oslo)"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.12.4642-4652.1995"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198409000-00001"},{"key":"e_1_3_1_36_2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4049\/jimmunol.33.1.51","article-title":"The bactericidal power of blood and protection against the meningococcal infection","volume":"33","author":"Silverthorne H.","year":"1937","unstructured":"Silverthorne H. The bactericidal power of blood and protection against the meningococcal infection.J. Immunol.3319375156","journal-title":"J. Immunol."},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI101406"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.7.2745-2751.1996"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.33.9.2324-2327.1995"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00415494"},{"key":"e_1_3_1_41_2","unstructured":"Zollinger W. D. Brandt B. L. Tramont E. C. Dobek A. S. Immune response to Neisseria meningitidis Manual of clinical Laboratory immunology 3rd ed. Rose N. R. Friedman H. Fahey J. L. 1986 446 453 American Society for Microbiology Washington D.C."},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.40.1.257-264.1983"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.38.8.2878-2884.2000","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.38.8.2878-2884.2000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T15:02:21Z","timestamp":1695567741000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.38.8.2878-2884.2000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["10.1128\/JCM.38.8.2878-2884.2000"],"URL":"https:\/\/doi.org\/10.1128\/jcm.38.8.2878-2884.2000","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8]]},"assertion":[{"value":"2000-02-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-05-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}